Shire ’s lyophilised Oncaspar receives positive CHMP opinion for ALL in Europe

Irish-headquartered biopharmaceutical company Shire ’s lyophilised Oncaspar (pegaspargase) has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for patients with acute ly…
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news